Factors Associated with Early Mortality in Patients Treated with Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 94, Issue 3, 2016, Pages 612-620

  Warner, Andrew ^a   Dahele, Max ^b   Hu, Bo ^a   Palma, David A ^a   Senan, Suresh ^b   Oberije, Cary ^c   Tsujino, Kayoko ^d   Moreno Jimenez, Marta ^e   Kim, Tae Hyun ^f   Marks, Lawrence B ^g   Rengan, Ramesh ^h   De Petris, Luigi ⁱ   Ramella, Sara ^j   De Ruyck, Kim ^k   De Dios, Núria Rodriguez ^l   Bradley, Jeffrey D ^m   Rodrigues, George ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRO CLINIC   (Netherlands)

^d HYOGO CANCER CENTER   (Japan)

^e UNIVERSITY CLINIC OF NAVARRA   (Spain)

^f National Cancer Center   (South Korea)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^k GHENT UNIVERSITY   (Belgium)

^l HOSPITAL DE L ESPERANÇA   (Spain)

^m WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; CHEMORADIOTHERAPY; DIAGNOSIS; DISEASES; FACTOR ANALYSIS; MULTIVARIANT ANALYSIS; NOMOGRAMS; PATIENT MONITORING; REGRESSION ANALYSIS; RISK ASSESSMENT; UNMANNED AERIAL VEHICLES (UAV);

CONCURRENT CHEMORADIATION; FORCED EXPIRATORY VOLUME IN 1; LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCERS; METHODS AND MATERIALS; MULTI VARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSIONS; RECURSIVE PARTITIONING ANALYSIS; RISK STRATIFICATION;

PATIENT TREATMENT;

ETOPOSIDE; PLATINUM;

ADULT; ADVANCED CANCER; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE ASSOCIATION; ESOPHAGITIS; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOMOGRAM; NON SMALL CELL LUNG CANCER; PNEUMONIA; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION PNEUMONIA; RETROSPECTIVE STUDY; STRATIFICATION; SURVIVAL RATE; TUMOR VOLUME; ADVERSE EFFECTS; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; ESOPHAGUS; FACTUAL DATABASE; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; RADIATION RESPONSE; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TIME FACTOR; VERY ELDERLY; VITAL CAPACITY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; DATABASES, FACTUAL; ESOPHAGUS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOMOGRAMS; PROGNOSIS; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR BURDEN; VITAL CAPACITY;

EID: 84963724930     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.11.030     Document Type: Article

References (19)

1. J. Vansteenkiste, D. De Ruysscher, W.E. Eberhardt, and et al. for the ESMO Guidelines Working Group. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 24 Suppl 6 2013 vi89 vi98
2. N. Ramnath, T.J. Dilling, L.J. Harris, and et al. Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 143 Suppl 5 2013 314S 340S
3. N. O'Rourke, I. Roqué, M. Figuls, and et al. Concurrent chemoradiotherapy in non-small cell lung cancer Cochrane Database Syst Rev 2010 CD002140
4. A. Aupérin, C. Le Péchoux, E. Rolland, and et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190
5. D.A. Palma, S. Senan, K. Tsujino, and et al. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis Int J Radiat Oncol Biol Phys 85 2013 444 450
6. D.A. Palma, S. Senan, C. Oberije, and et al. Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: An individual patient data meta-analysis Int J Radiat Oncol Biol Phys 87 2013 690 696
7. G. Rodrigues, S. Senan, C. Oberije, and et al. Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small cell lung cancer beneficial?: A multi-institutional propensity-score matched analysis Int J Radiat Oncol Biol Phys 90 2014 S654
8. J.D. Bradley, R. Paulus, R. Komaki, and et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIa or IIIb non-small-cell lung cancer (RTOG 0617): A randomized, two-by-two factorial phase 3 study Lancet Oncol 16 2015 187 199
9. J.D. Cox Are the results of RTOG 0617 mysterious? Int J Radiat Oncol Biol Phys 82 2012 1042 1044
10. J. Zhang, K.A. Gold, H.Y. Lin, and et al. Relationship between tumor size and survival in non-small cell lung cancer (NSCLC): An analysis of the Surveillance, Epidemiology, and End Results (SEER) registry J Thorac Oncol 10 2015 682 690
11. D. Morgensztern, S. Waqar, J. Subramanian, and et al. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: A surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003 J Thorac Oncol 7 2012 1479 1484
12. L. De Petris, I. Lax, F. Sirzén, and et al. Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non- small cell lung cancer Med Oncol 22 2005 375 381
13. K. Basaki, Y. Abe, M. Aoki, and et al. Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume Int J Radiat Oncol Biol Phys 64 2006 449 454
14. F.O. Ademuyiwa, C.S. Johnson, A.S. White, and et al. Prognostic factors in stage III non-small-cell lung cancer Clin Lung Cancer 8 2007 478 482
15. A. Brunelli, A. Charloux, C.T. Bolliger, and et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Eur Respir J 34 2009 17 41
16. T. Kawaguchi, M. Takada, A. Kubo, and et al. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: A comprehensive analysis of 26,957 patients with NSCLC J Thorac Oncol 5 2010 620 630
17. M.S. Lara, A. Brunson, T. Wun, and et al. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): A California Cancer Registry analysis Lung Cancer 85 2014 264 269
18. B. Movsas, J. Moughan, L. Sarna, and et al. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: An analysis of RTOG 9801 J Clin Oncol 27 2009 5816 5822
19. M. Machtay, F. Duan, B.A. Siegel, and et al. Prediction of survival by (18F)fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: Results of the ACRIN 6668/RTOG 0235 trial J Clin Oncol 31 2013 3823 3830